| Stable intranasal formulations of carbetocin |
2023-2-21 |
2023-6-29 |
|
| Crystalline forms of trofinetide |
2022-7-12 |
2023-1-26 |
|
| Modulators of g protein-coupled receptor 88 |
2022-6-22 |
2022-8-10 |
|
| Modulators of g protein-coupled receptor 88 |
2022-6-22 |
2022-8-10 |
|
| Methods of treating, ameliorating, and/or preventing osteoarthritic pain |
2022-6-15 |
2022-12-22 |
|
| Methods and compositions for the treatment of rett syndrome |
2022-5-31 |
2022-8-30 |
|
| Compounds, salts thereof and methods for treatment of diseases |
2022-5-27 |
2022-9-22 |
|
| Formulations of pimavanserin |
2022-3-14 |
2022-6-23 |
|
| Carbetocin drug product and process for preparing same |
2022-3-02 |
2023-1-19 |
|
| Modulators of g protein-coupled receptor 88 |
2021-12-17 |
2023-10-25 |
|
| Methods of treating pain with a thiazoline anti-hyperalgesic |
2021-11-03 |
2022-6-02 |
|
| Compounds for treating psychosis or depression |
2021-10-29 |
2022-5-05 |
|
| Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent |
2021-10-05 |
2022-8-25 |
|
| Selective serotonin 2a/2c receptor inverse agonists as therapeutics for … |
2021-9-14 |
2022-8-04 |
|
| Compounds for Pain Treatment, Compositions Comprising Same, and Methods of … |
2021-7-06 |
2022-5-19 |
|
| Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2- … |
2021-3-16 |
2022-1-27 |
|
| 5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing … |
2021-2-16 |
2022-1-06 |
|
| Methods for treating dementia related psychosis |
2020-12-01 |
2021-6-03 |
|
| Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic … |
2020-8-21 |
2021-4-08 |
|
| Pimavanserin for treating neurodegenerative diseases |
2020-8-13 |
2021-2-18 |
|
| Pimavanserin for trating schizophrenia or for treating psychosis secondary to … |
2020-7-22 |
2021-1-28 |
|
| Combination of pimavanserin and cytochrome p450 modulators |
2019-11-15 |
2020-3-12 |
|
| Methods of treating depression, anxiety and sexual dysfunction using the … |
2019-10-30 |
2020-5-07 |
|
| Methods for assessing suicidality |
2019-3-11 |
2019-9-19 |
|
| Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic … |
2019-3-04 |
2020-2-27 |
|
| Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor … |
2019-2-20 |
2021-6-15 |
2021-6-15 |
| Compounds, salts thereof and methods for treatment of diseases |
2018-8-20 |
2019-2-28 |
|
| Compounds, salts thereof and methods for treatment of diseases |
2018-8-20 |
2019-2-28 |
|
| Compounds, salts thereof and methods for treatment of diseases |
2018-8-20 |
2019-2-28 |
|
| Pimavanserin for treating impulse control disorder |
2018-4-27 |
2020-2-27 |
|
| Pimavanserin alone or in combination for use in the treatment of alzheimer's … |
2017-12-14 |
2020-7-30 |
|
| 5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing … |
2017-3-28 |
2019-4-25 |
|
| Combination of pimavanserin and cytochrome P450 modulators |
2017-3-23 |
2021-3-23 |
2021-3-23 |
| Azacyclic Compounds for Use in Therapeutic Treatment of Serotonin-Related … |
2017-1-18 |
2017-7-12 |
|
| Methods for the treatment of parkinson's disease psychosis using pimavanserin |
2016-8-24 |
2017-2-16 |
|
| Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and … |
2015-11-04 |
2018-5-30 |
|
| Muscarinic agonists |
2015-9-01 |
2015-11-30 |
|
| Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
2015-5-01 |
2015-8-20 |
|
| Treatment of a neurodegenerative disease or disorder |
2014-10-21 |
2015-4-30 |
|
| Co-administration of pimavanserin with other agents |
2014-5-28 |
2014-11-27 |
|
| Compounds and compositions for treating neurodegenerative diseases |
2014-2-18 |
2014-8-21 |
|
| Tetrahydroquinoline analogues as muscarinic agonists |
2014-2-05 |
2016-12-20 |
2016-12-20 |
| Treatment of neurodegenerative diseases |
2012-8-07 |
2014-2-06 |
|
| Diphenyl substituted cyclohexane derivatives, useful as modulators of the … |
2012-8-01 |
2015-6-23 |
2015-6-23 |
| Compounds with activity at estrogen receptors |
2011-12-14 |
2013-6-25 |
2013-6-25 |
| Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2- … |
2011-4-06 |
2012-8-07 |
2012-8-07 |
| Compounds with activity at estrogen receptors |
2010-10-29 |
2014-9-02 |
2014-9-02 |
| Amino substituted diaryl [a, d] cycloheptene analogs as muscarinic agonists and … |
2010-8-23 |
2011-3-03 |
|
| Benzimidazolidinone derivatives as muscarinic agents |
2010-5-07 |
2010-8-26 |
|
| N-substituted piperidine derivatives as serotonin receptor agents |
2010-3-24 |
2010-9-30 |
|
| AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND … |
2009-11-18 |
2010-5-27 |
|
| Muscarinic agonists |
2009-10-26 |
2010-6-03 |
|
| Spiroazacyclic compounds as monoamine receptor modulators |
2009-9-11 |
2009-10-08 |
|
| AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND … |
2009-2-12 |
2009-9-24 |
|
| Selective serotonin receptor inverse agonists as therapeutics for disease |
2009-2-11 |
2009-6-18 |
|
| Use of n-desmethylclozapine to treat human neuropsychiatric disease |
2008-9-22 |
2009-1-15 |
|
| N-substituted piperidine derivatives as serotonin receptor agents |
2008-9-19 |
2009-3-26 |
|
| Use of pimavanserin in the treatment of parkinson and symptoms thereof |
2008-5-19 |
2008-11-27 |
|
| Synthesis of n-(4-fluorobenzyl)-n-(l-methylpiperidin-4-yl)-n'-(4- (2- … |
2008-5-13 |
2009-3-26 |
|
| Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid … |
2008-5-09 |
2010-2-24 |
|
| Cb-1 modulating compounds and their use |
2008-4-17 |
2009-6-18 |
|
| Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
2008-3-19 |
2013-9-30 |
|
| Muscarinic agonist |
2008-2-07 |
2008-6-12 |
|
| Compounds with activity at retinoic acid receptors |
2007-11-16 |
2008-7-10 |
|
| Uii-modulating compounds and their use |
2007-11-06 |
2008-5-15 |
|
| Compounds for the treatment of pain and screening methods therefor |
2007-10-24 |
2008-10-09 |
|
| Use of cannabinoid modulating compounds in combination with other therapeutic … |
2007-10-17 |
2008-12-24 |
|
| Cb1-modulating compounds and their use |
2007-10-17 |
2008-6-12 |
|
| Compounds with activity at estrogen receptors |
2007-9-12 |
2008-3-20 |
|
| Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and … |
2007-8-15 |
2008-2-21 |
|
| N-substituted piperidine derivatives as serotonin receptor agents |
2007-7-24 |
2010-3-11 |
2010-3-11 |
| Androgen receptor modulators and method of treating disease using the same |
2007-6-28 |
2008-1-10 |
|
| Use of n-desmethylclozapine to treat psychosis |
2007-6-26 |
2008-1-03 |
|
| Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and … |
2007-6-04 |
2009-2-25 |
|
| Pharmaceutical formulations of pimavanserin |
2007-5-15 |
2007-11-22 |
|
| Pharmaceutical formulations of pimavanserin |
2007-5-15 |
2009-8-05 |
|
| Muscarinic agonists |
2007-4-24 |
2007-5-17 |
|
| Use of 4-amino-piperidines for treating sleep disorders |
2007-4-18 |
2007-11-01 |
|
| Use of 4-amino-piperidines for treating sleep disorders |
2007-4-18 |
2008-2-28 |
|
| Enabling methods to identify allosteric modulators of receptor activity |
2007-2-14 |
2008-12-04 |
|
| Aminophenyl derivatives as selective androgen receptor modulators |
2007-2-06 |
2007-8-16 |
|
| Use of n-desmethylclozapine to treat human neuropsychiatric disease |
2007-2-05 |
2007-11-29 |
|
| Androgen receptor modulators and methods of treating disease using the same |
2007-2-05 |
2007-8-16 |
|
| Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof |
2006-12-29 |
2007-7-12 |
|
| Substituted phenethylamines with serotoninergic and/or norepinephrinergic … |
2006-11-30 |
2009-12-17 |
|
| Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric … |
2006-10-31 |
2007-5-10 |
|
| Crystalline forms of N-desmethylclozapine |
2006-10-25 |
2008-5-28 |
|
| Cb-1 modulating compounds and their use |
2006-10-17 |
2007-4-26 |
|
| Iron catalyzed cross-coupling reactions of imidoyl derivatives |
2006-10-17 |
2008-7-02 |
|
| Iron catalyzed cross-coupling reactions of imidoyl derivatives |
2006-10-17 |
2008-10-29 |
|
| Compositions and methods for use in cancer therapy |
2006-10-16 |
2007-6-21 |
|
| Compounds with activity at retinoic acid receptors |
2006-7-12 |
2008-4-09 |
|
| Uii-modulating compounds and their use |
2006-6-08 |
2006-12-21 |
|
| Par2-modulating compounds and their use |
2006-5-17 |
2006-11-30 |
|
| Par2-modulating compounds and their use |
2006-5-17 |
2006-11-30 |
|
| Use of the lipoxin receptor, fprl1, as a tool for identifying compounds … |
2006-5-04 |
2006-10-17 |
|
| Muscarinic agonists |
2006-5-03 |
2006-9-07 |
|
| Benzimidazolidinone derivatives as muscarinic agents |
2006-5-03 |
2007-11-27 |
2007-11-27 |
| N-substituted piperidine derivatives as serotonin receptor agents |
2006-5-03 |
2006-9-07 |
|
| High troughput functional assay for g-protein coupled receptors using a rap-ras … |
2006-5-02 |
2006-10-17 |
|